STOCK MARKET BSE NSE

WHO call on Covaxin approval deferred by a month, likely in September

The WHO assessment for approving Covaxin has been deferred by a month. It  has now said it will take a decision on including it in the emergency use list by September. 

Published: 13th August 2021 04:05 AM  |   Last Updated: 13th August 2021 08:30 AM   |  A+A-

A health worker displays empty vials of COVAXIN at a vaccination center. (Photo | AP)

By Express News Service

NEW DELHI:  The WHO assessment for approving Covaxin has been deferred by a month. It  has now said it will take a decision on including it in the emergency use list by September. 

The agency and Covaxin developer Bharat Biotech had earlier said a decision on the recognition of the vaccine was likely in August. 

A senior WHO official has now said that the agency’s assessment of the made-in-India Covaxin is at an advanced stage and a decision on emergency authorisation for Bharat Biotech’s vaccine is likely by mid-September. 

Covaxin is still to be authorised in Western countries, leading to hassle to thousands of students and other professionals who have taken the vaccine in India but are moving to these countries. 

Mariangela Simao, a WHO assistant director-general for vaccines, said the UN health agency’s assessment of this vaccine was “quite advanced” and officials hoped for a decision by mid-September.

Meanwhile, following a meeting with WHO’s chief scientist Soumya Swaminathan on Thursday,  the Union health minister tweeted,  “We had a productive discussion on WHO’s approval of Bharat Biotech’s Covaxin.”

As per data released by Bharat Biotech from its late-stage clinical trials, the vaccine, developed jointly with ICMR, was found to be nearly 78% effective against symptomatic infection but many experts say its efficacy against more transmissible variants still needs to be assessed. 



Comments(2)

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

  • anonymous

    Looks like its a deliberate attempt to approve Indian made vaccine
    10 days ago reply
  • Allan Gracias

    fake chinese vaccines are approved but covaxin is delayed?
    20 days ago reply
flipboard facebook twitter whatsapp